6H-Thieno, Triazolo, Diazepine, 4-(2-chlorophenyl)-2-ethyl-9-methyl-
Etizolam is a benzodiazepine type compound. Effects of Etizolam could be moderate to mild, depending on the strength. One of the most common effects is sleepiness during daytime. Other effects include thirst, jaundice, rash, nausea and weakness.
DRUG FORM & METHOD OF USE:
Etizolam is sold in pellets (which can be pulled about for powder) that are per-measured and sold for lab research only and strictly not for human consumption. Having multiple therapeutic properties, the drug is used to treat depression, panic disorder, anxiety, sleep disorders sometimes. There has been one clinical trial that proves Etizolam to reduce symptoms of anxiety and depression effectively.
HEALTH RISKS (long term) which includes withdrawal & tolerance:
The long term effects of using Etizolam include memory loss, disturbing nighttime dreams, hostile behaviour and addiction. Severe withdrawal symptoms are seen among those people who suddenly stop taking the drug. Higher doses can lead to hypnotic effects. There is, at present, very little direct evidence of actual abuse of Etizolam. There are currently no reports of illicit trafficking, production or diversion of Etizolam. The Committee noted the relatively limited distribution of the drug and the short period of time since it was introduced into the market.
Etizolam Pellets are for research purposes only and they are not intended for human consumption. They can be obtained online legally.